The function of EMSY in cancer development

Jing Hou1, Ziliang Wang, Lina Yang

  • 1Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Insights

The EMSY gene binds BRCA2, inactivating its function and promoting breast and ovarian cancers. EMSY amplification is also linked to prostate and pancreatic cancers, affecting tumor traits and outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The EMSY gene interacts with BRCA2, inhibiting its tumor-suppressive functions.
  • EMSY's role in DNA damage repair, genomic instability, and chromatin remodeling is implicated in cancer.
  • Amplification of EMSY has been observed in various cancers, including breast, ovarian, prostate, and pancreatic types.

Purpose of the Study:

  • To review recent literature on the role of EMSY in cancer development.
  • To summarize the association between EMSY and different cancer types.
  • To highlight EMSY's impact on tumor phenotypes and clinical outcomes.

Main Methods:

  • Literature review of studies published since 2003.
  • Analysis of research on EMSY's interaction with BRCA2.
  • Examination of studies linking EMSY amplification to various cancers.

Main Results:

  • EMSY inactivation of BRCA2 is a key mechanism in sporadic breast and ovarian cancer.
  • EMSY amplification correlates with adverse tumor phenotypes and clinical outcomes in prostate and pancreatic cancers.
  • EMSY's functions extend to DNA repair, genomic stability, and chromatin regulation.

Conclusions:

  • EMSY is a significant factor in the development and progression of multiple cancer types.
  • Targeting EMSY may offer potential therapeutic strategies for various cancers.
  • Further research into EMSY's multifaceted roles is warranted.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K